Nuveen
ETON icon

Nuveen’s Eton Pharmaceutcials ETON Stock Holding History

Nuveen’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Buy
375,707
+317,757
+548% +$9.32M ﹤0.01% 1499
2026
Q1 		$1.43M Sell
57,950
-967
-2% -$16.9K ﹤0.01% 2403
2025
Q4 		$996K Hold
58,917
– – ﹤0.01% 2618
2025
Q3 		$1.28M Hold
58,917
– – ﹤0.01% 2501
2025
Q2 		$840K Buy
+58,917
New +$931K ﹤0.01% 2685
2021
Q2 		– Sell
-37,204
Closed -$272K – 3421
2021
Q1 		$272K Sell
37,204
-1,951
-5% -$16.6K ﹤0.01% 3192
2020
Q4 		$318K Buy
39,155
+986
+3% +$7.61K ﹤0.01% 3122
2020
Q3 		$301K Hold
38,169
– – ﹤0.01% 3087
2020
Q2 		$208K Buy
+38,169
New +$190K ﹤0.01% 3097

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Nuveen's ETON Position: Q2 2026 in Review

Nuveen increased its Eton Pharmaceutcials (ETON) stake by 548% in Q2 2026, buying an estimated $9.32M and bringing the position to 375,707 shares worth $13.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1499.

Nuveen first reported a position in ETON in Q2 2020 and has held it in 9 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Nuveen held 375,707 shares of Eton Pharmaceutcials worth $13.6M as of Q2 2026.
  • Nuveen bought 317,757 Eton Pharmaceutcials shares in Q2 2026, an estimated $9.32M.
  • Eton Pharmaceutcials made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1499 holding.
  • Nuveen first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 9 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.